Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.

ALS is a slow progressing disease that doesn’t show symptoms right away. Dropping things often can be an early sign.

Columnist Juliet Taylor used to face difficulties with stoicism, but her late husband's ALS diagnosis forced to her feel her ...

The Longitude Prize on ALS is offering £7.5 million to encourage scientists to use AI to speed up the search for new treatments.

A new clinic at Vanderbilt University Medical Center is a ray of light for patients like Louis Del Ray, who was diagnosed ...

Thomas Mulligan explains how a brain implant enables ALS patients to control digital devices. Canada rescinds Digital Services Tax after Trump cuts off U.S. trade talks ...

The Food and Drug Administration has granted Fast Track designation to AMX0114 for the treatment of amyotrophic lateral sclerosis (ALS).

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic ...

Living close to cyanobacterial harmful algal blooms in US water bodies is associated with increased risk of mortality from ALS.

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness ...

Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis (ALS) failed to show efficacy in part of the phase 2/3 HEALEY ALS basket trial, causing a fall in its share price.

Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 HEALEY ALS basket trial, which is trying to accelerate the search for ...